stockhead on MSN3h
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue feverJapan’s Takeda recently withdrew its US Food & Drug Administration (FDA) approval application for another vaccine, Qdenga ...
Golf is hitting the home stretch with the four main tours in action. Rory McIlroy leads the field in Abu Dhabi in the first ...
The Loop on MSN8h
Charley Hull’s (forced) cig break, Nelly Korda’s SI Swimsuit nod and Bryson DeChambeau’s big-man-on-campus moveBut he still followed along in a golf cart with the former President, teammate Saquon Barkley (Did Barack teach Saquon that ...
Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...
Prediabetes market size is estimated to reach USD 360.6 million by the end of 2032. The industry growth is driven by the ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new. Dr. Lopez brings more than two decades of clinical ...
Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company ...
With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that ...
Stifel has upgraded Alkermes (ALKS) to buy from hold, citing increased confidence in the company’s narcolepsy drug candidate ALKS2680. Read more here.
following positive recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback